Enochian Biosciences, Inc. Profile Avatar - Palmy Investing

Enochian Biosciences, Inc.

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza an…

Biotechnology
US, Los Angeles [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Enochian Biosciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ENOB's Analysis
CIK: - CUSIP: 29350E104 LEI: - UEI: -
Secondary Listings
ENOB has no secondary listings inside our databases.